Food News and Research

RSS

VISINE launches new Maximum Redness Relief Formula

Now irritated, red eyes can get the fast, effective relief they need with the launch of NEW VISINE® Maximum Redness Relief Formula. Plus, the free new VISINE® Red Eye Remover Application lets iPhone® and iPod® Touch users eliminate red eye from their photos in moments.

24 Jun 2010

Warren Mosler signs pledge to never vote for any reductions in Medicare benefits

Warren Mosler, a leading voice in the fight against the bipartisan move to slash Social Security and Medicare, has signed a University of Missouri Kansas City economics department pledge to never vote for any reductions in Social Security or Medicare benefits, or any delays in eligibility.

24 Jun 2010

Scientists describe development of special sensor that uses maglev for analyzing food, beverages

Scientists are reporting development of a new use for magnetic levitation, or "maglev," the futuristic technology best known for enabling high-speed passenger trains to float above the tracks. In ACS' bi-weekly Journal of Agricultural and Food Chemistry, they describe putting maglev to use in an inexpensive sensor for analyzing food, water, and other beverages.

24 Jun 2010

Spherix to explore triglycerides for D-tagatose therapy

Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.

24 Jun 2010

New poll illustrates difficult situations cancer patients face in affording needed health care

A new poll illustrates the difficulty that cancer patients, survivors and their families face in affording needed health care and paying for other basic necessities such as food and heat, underscoring the need to strongly implement the Affordable Care Act so that it works for people with cancer.

24 Jun 2010

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.

24 Jun 2010

Pfizer announces suspension of osteoarthritis clinical program for tanezumab

Pfizer Inc. announced today the suspension of the osteoarthritis clinical program for the investigational compound tanezumab following a request by the U.S. Food and Drug Administration. The worldwide suspension – which is effective immediately – follows a small number of reports of tanezumab patients experiencing the worsening of osteoarthritis leading to joint replacement.

24 Jun 2010

FDA schedules Advisory Committee meeting to review Orexigen's Contrave NDA

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.

24 Jun 2010

Treatment options for patients with MS

The best one-word description for multiple sclerosis is "unpredictable," according to the June issue of Mayo Clinic Women's HealthSource. MS interferes with the communication between the brain and the rest of the body. Just how that interference plays out in symptoms is different for everyone -- thus, the unpredictable label.

24 Jun 2010

Biosense Webster's CARTOXPRESS Module, LASSO NAV Circular Mapping Catheter receive FDA clearance

Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today that the U.S. Food and Drug Administration (FDA) has cleared for marketing the CARTOXPRESS™ Software Module and the LASSO® NAV Circular Mapping Catheter for use with the CARTO® XP Mapping System.

24 Jun 2010

Advaxis completes enrollment of vanguard patient group in phase II clinical trial for cervical intraepithelial neoplasia

Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Lm) biotechnology company, enrolled and has administered its initial dose to its third patient in its US Food and Drug Administration (FDA)-approved, phase II clinical trial in cervical intraepithelial neoplasia (CIN), commonly known as cervical dysplasia.

24 Jun 2010

Watson's ANDA for Fentanyl Citrate Buccal tablets receives tentative FDA approval

Watson Pharmaceuticals, Inc. announced that its subsidiary, Watson Laboratories, Inc. has received tentative approval today from the United States (U.S.) Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Fentanyl Citrate Buccal tablets, 100 mcg, 200 mcg, 300 mcg, 400 mcg, 600 mcg and 800 mcg.

24 Jun 2010

BSD Medical showcases MicroThermX Microwave Ablation System at WCIO 2010 meeting

BSD Medical Corporation today announced that the Company exhibited the MicroThermX® Microwave Ablation System at the World Conference on Interventional Oncology (WCIO) meeting, which was held June 9 to June 12, 2010, in Philadelphia, Pennsylvania.

23 Jun 2010

AstraZeneca, Targacept commence enrollment in TC-5214 Phase 3 clinical development for MDD

AstraZeneca and Targacept, Inc., today announced the enrollment of the first patient in the Phase 3 clinical development program for TC-5214, a nicotinic channel blocker.

23 Jun 2010

BASF signs agreement to acquire Cognis for equity purchase price of euro 700 million

BASF SE has reached an agreement with Cognis Holding Luxembourg S.a r.l. controlled by Permira Funds, GS Capital Partners and SV Life Sciences to acquire the specialty chemicals company Cognis for an equity purchase price of euro 700 million. Including net financial debt and pension obligations, the enterprise value of the transaction is euro 3.1 billion. The acquisition is subject to clearance by the competent merger control authorities. Closing of the transaction is expected for November 2010 at the latest.

23 Jun 2010

K-State chemical engineer patents chemical structure to make natural personal care products in lab

A Kansas State University chemical engineer has developed and patented a chemical structure to make all-natural personal care products and purer pharmaceuticals in the laboratory.

23 Jun 2010

Educational comic strips can help young girls make better food choices, improve physical fitness: Study

Lively, educational comic strips, geared to 8- to 10-year-old African-American girls, can help these young viewers make better food choices and improve their physical fitness. That's what happened in a preliminary study, reported several years ago, with 78 Internet-savvy African American girls age 8 to 10. Now, the program's creators hope to repeat the study in a larger test with 400 young volunteers and their parents. The scientists also want to develop a version targeted to Hispanic girls.

23 Jun 2010

Four new EVP grants awarded for interdisciplinary research to tackle environmental challenges

The Woods Institute for the Environment at Stanford University has awarded four new Environmental Venture Projects grants for interdisciplinary research aimed at finding practical solutions promoting global sustainability.

23 Jun 2010

Global weight management ingredients market to reach $13.9 million by 2015

Obesity rates, which have been steadily rising in Europe and the United States, are now increasing in Asian nations as well. While healthy eating and lifestyle management are the key solutions to weight management, they remain challenging for many consumers. As a result, the weight management ingredients market offers significant prospects worldwide.

23 Jun 2010

Preschool children with tooth decay more likely to be obese: Study

Preschool children with tooth decay may be more likely to be overweight or obese than the general population and, regardless of weight, are more likely to consume too many calories, a new study indicates. The results will be presented Saturday at The Endocrine Society's 92nd Annual Meeting in San Diego.

23 Jun 2010

Food News and Research

VISINE launches new Maximum Redness Relief Formula

Warren Mosler signs pledge to never vote for any reductions in Medicare benefits

Scientists describe development of special sensor that uses maglev for analyzing food, beverages

Spherix to explore triglycerides for D-tagatose therapy

New poll illustrates difficult situations cancer patients face in affording needed health care

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

Pfizer announces suspension of osteoarthritis clinical program for tanezumab

FDA schedules Advisory Committee meeting to review Orexigen's Contrave NDA

Treatment options for patients with MS

Biosense Webster's CARTOXPRESS Module, LASSO NAV Circular Mapping Catheter receive FDA clearance

Advaxis completes enrollment of vanguard patient group in phase II clinical trial for cervical intraepithelial neoplasia

Watson's ANDA for Fentanyl Citrate Buccal tablets receives tentative FDA approval

BSD Medical showcases MicroThermX Microwave Ablation System at WCIO 2010 meeting

AstraZeneca, Targacept commence enrollment in TC-5214 Phase 3 clinical development for MDD

BASF signs agreement to acquire Cognis for equity purchase price of euro 700 million

K-State chemical engineer patents chemical structure to make natural personal care products in lab

Educational comic strips can help young girls make better food choices, improve physical fitness: Study

Four new EVP grants awarded for interdisciplinary research to tackle environmental challenges

Global weight management ingredients market to reach $13.9 million by 2015

Preschool children with tooth decay more likely to be obese: Study

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News